DJ West Pharmaceutical Services Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of West Pharmaceutical Services Inc. (WST) slipped 2.64% to $321.55 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.95% to 6,025.99 and Dow Jones Industrial Average falling 0.99% to 44,303.40.
This was the stock's second consecutive day of losses.
West Pharmaceutical Services Inc. closed 22.08% below its 52-week high of $412.67, which the company reached on February 9th.
The stock underperformed when compared to some of its competitors Friday, as Abbott Laboratories $(ABT)$ rose 0.66% to $129.07, Becton Dickinson & Co. $(BDX)$ rose 1.16% to $229.85, and Baxter International Inc. $(BAX)$ fell 0.62% to $30.62.
Trading volume (341,166) remained 125,086 below its 50-day average volume of 466,252.
Data source: Dow Jones Market Data, FactSet. Data compiled February 7, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 07, 2025 17:04 ET (22:04 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。